Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 known ✓ | Q99720 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 9/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29459702 | 1.00 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL60763 | 0.97 | — | — | |
| SCHEMBL29861109 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL23326973 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| Bromide SCHEMBL30099792 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| Iodide SCHEMBL29564978 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| Iodide SCHEMBL16149430 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL29940088 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| Bromide SCHEMBL30657202 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| Methane SCHEMBL27608288 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-2329059-Y | Quick look-up instrument for incompatibility of drugs in a prescription of 159 kind of injections | GU CHUNWEI (CN) | 1999-07-14 | — | — | CN | claimed |
| CN-108778272-A | Percutaneous absorption preparation | KM特兰斯达股份有限公司 | 2018-11-09 | — | — | CN | disclosed |
| CN-107427484-A | The self-emulsifying composition of omega-3 fatty acid | 持田制药株式会社 | 2017-12-01 | — | — | CN | disclosed |
| CN-101432383-B | Non-aqueous adhesive composition, patch, and method for producing patch | LION CORP | 2013-05-01 | — | — | CN | disclosed |
| CN-102791284-A | Method for treating or preventing hair loss or promoting hair growth | ADVANGEN INTERNAT PTY LTD | 2012-11-21 | — | — | CN | disclosed |
| CN-101816638-A | Methods and formulations for modulating the human sexual response | REPROS THERAPEUTICS INC | 2010-09-01 | — | — | CN | disclosed |
| CN-101432383-A | Non-aqueous adhesive composition, plaster and process for producing plaster | LION CORP (JP) | 2009-05-13 | — | — | CN | disclosed |
| CN-1159002-C | percutaneous absorption type preparation | �ù���ҩ��ʽ���� | 2004-07-28 | — | — | CN | disclosed |
| CN-1095681-C | Device structure for iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 2002-12-11 | — | — | CN | disclosed |
| CN-1346265-A | Preparations for percutaneous absorption | HISAMITSU PHARMACEUTICAL CO (JP) | 2002-04-24 | — | — | CN | disclosed |
| EP-1194118-A1 | AGENT FOR COLORING FIBERS | Wella Aktiengesellschaft (DE) | 2002-04-10 | — | — | EP | disclosed |
| CN-1080559-C | Method of production of sustained-release preparation | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-03-13 | — | — | CN | disclosed |
| WO-2001085111-A1 | AGENT FOR COLORING FIBERS | WELLA AKTIENGESELLSCHAFT (DE) | 2001-11-15 | — | — | WO | disclosed |
| CN-2369307-Y | Instrument for checking inhibition of mixed preparations | REN YONGHONG (CN) | 2000-03-15 | — | — | CN | disclosed |
| CN-2329059-Y | Quick look-up instrument for incompatibility of drugs in a prescription of 159 kind of injections | GU CHUNWEI (CN) | 1999-07-14 | — | — | CN | disclosed |
| CN-1221398-A | Mannitol and its preparation | BAYER AG (DE) | 1999-06-30 | — | — | CN | disclosed |
| CN-1187767-A | Methods and formulations for modulating human sexual response | ZONAGEN INC (US) | 1998-07-15 | — | — | CN | disclosed |
| CN-1171278-A | Device structure for iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 1998-01-28 | — | — | CN | disclosed |
| CN-1148956-A | Method of production of sustained-release preparation | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1997-05-07 | — | — | CN | disclosed |